Correvio Pharma Quick Ratio (CORV) starting from the fourth quarter 2019 to fourth quarter 2018, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Correvio Pharma Corp   (CORV)

Correvio Pharma 's Quick Ratio

CORV's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2019, Quick Ratio fell to 0.43 below Correvio Pharma Corp average.

Within Major Pharmaceutical Preparations industry 418 other companies have achieved higher Quick Ratio than Correvio Pharma in fourth quarter 2019. While Quick Ratio total ranking has improved so far during the Q4 2019 to 2549, from total ranking in the third quarter 2019 at 2585.

Explain Quick Ratio?
How much Cash & cash equivalents CORV´s has?
What are CORV´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CORV Quick Ratio (Dec 31 2019)
Q4		 0
Q3		 0
Q2		 0
Q1		 (Dec 31 2018)
Q4
Y / Y Current Liabilities Change 160.97 % 208.23 % 208.23 % 208.23 % 14.28 %
Y / Y Cash & cash equivalent Change -13.24 % -14.73 % -14.73 % -14.73 % -27.34 %
Quick Ratio MRQ 0.43 0.46 0.46 0.46 1.29
CORV's Total Ranking # 2549 # 2585 # 2555 # 2560 # 1365
Seq. Current Liabilities Change 22.6 % 0 % 0 % 112.86 % 44.8 %
Seq. Cash & cash equivalent Change 14.63 % 0 % 0 % -24.31 % 12.66 %



Quick Ratio fourth quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 419
Healthcare Sector # 739
Overall Market # 2549


Quick Ratio Statistics
High Average Low
2.79 1.6 0.46
(Dec 31 2017)   (Dec 31 2019)




Financial Statements
Correvio Pharma 's Current Liabilities $ 36 Millions Visit CORV's Balance sheet
Correvio Pharma 's Cash & cash equivalent $ 15 Millions Visit CORV's Balance sheet
Source of CORV's Sales Visit CORV's Sales by Geography


Cumulative Correvio Pharma 's Quick Ratio

CORV's Quick Ratio for the trailling 12 Months

CORV Quick Ratio

 (Dec 31 2019)
12 Months		 0
12 Months		 0
12 Months		 0
12 Months		 (Dec 31 2018)
12 Months
Y / Y Current Liabilities TTM Growth 192.85 % 150.64 % 109.65 % 65.36 % 17.36 %
Y / Y Cash & cash equivalent TTM Growth -14.32 % -19.03 % -22.84 % -26.06 % -28.83 %
Quick Ratio TTM 0.45 0.57 0.74 1.01 1.54
Total Ranking TTM # 5091 # 4912 # 2439 # 2439 # 4751
Seq. Current Liabilities TTM Growth 21.79 % 24.18 % 31.89 % 46.81 % 4.24 %
Seq. Cash & cash equivalent TTM Growth -4.05 % -3.84 % -3.7 % -3.57 % -9.32 %

Quick ratio ranking by company, industry and sector >> Back to CORV Financial Strength Comparisons >> Go to Compare CORV Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q4 2019 to $35.53 millions, cumulative Quick Ratio decreased to 0.45 below the Correvio Pharma Corp average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 488 other companies have achieved higher Quick Ratio than Correvio Pharma . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2019 from 4912 to 5091.

Explain Quick Ratio?
How much Cash & cash equivalents CORV´s has?
What are CORV´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 489
Healthcare Sector # 956
Within the Market # 5091


trailing twelve months Quick Ratio Statistics
High Average Low
2.79 1.52 0.45
(Dec 31 2017)   (Dec 31 2019)




Companies with similar Quick Ratio in the quarter ending Dec 31 2019, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2019 MRQ Cash & cash equivalentDec 31 2019 MRQ Current Liabilities
Opus Genetics Inc   1.16 $ 3.023  Millions$ 2.603  Millions
Dar Bioscience Inc   1.16 $ 4.780  Millions$ 4.117  Millions
Alkermes Plc   1.16 $ 534.979  Millions$ 463.184  Millions
Intec Pharma Ltd   1.12 $ 10.062  Millions$ 8.946  Millions
Medicure Inc   1.11 $ 9.931  Millions$ 8.933  Millions
Oncolytics Biotech Inc   1.10 $ 10.837  Millions$ 9.858  Millions
Omeros Corporation  1.10 $ 60.788  Millions$ 55.459  Millions
Camp4 Therapeutics Corporation  1.09 $ 103.560  Millions$ 94.892  Millions
Aridis Pharmaceuticals Inc   1.08 $ 20.897  Millions$ 19.331  Millions
Novan Inc   1.06 $ 13.711  Millions$ 12.899  Millions
Emmaus Life Sciences Inc   1.06 $ 29.698  Millions$ 28.087  Millions
Akari Therapeutics Plc  1.05 $ 5.732  Millions$ 5.457  Millions
Bausch Health Companies Inc   1.05 $ 3,243.000  Millions$ 3,097.000  Millions
Statera Biopharma Inc fka Cytocom Inc   1.04 $ 1.578  Millions$ 1.521  Millions
Regeneron Pharmaceuticals Inc   1.04 $ 3,214.300  Millions$ 3,100.700  Millions
Galapagos Nv  1.03 $ 656.900  Millions$ 640.408  Millions
Ani Pharmaceuticals Inc  1.01 $ 62.332  Millions$ 61.676  Millions
Dmk Pharmaceuticals Corporation  0.98 $ 8.811  Millions$ 8.965  Millions
Bellicum Pharmaceuticals Inc   0.96 $ 91.028  Millions$ 94.418  Millions
Biofrontera Ag  0.96 $ 12.483  Millions$ 12.999  Millions
Silo Pharma Inc  0.96 $ 0.112  Millions$ 0.117  Millions
Vbi Vaccines Inc  0.95 $ 44.213  Millions$ 46.323  Millions
Seelos Therapeutics inc   0.95 $ 10.261  Millions$ 10.778  Millions
Summit Therapeutics Inc   0.95 $ 28.495  Millions$ 30.052  Millions
Teligent Inc   0.93 $ 15.508  Millions$ 16.606  Millions
Nature s Sunshine Products inc   0.93 $ 53.629  Millions$ 57.947  Millions
Celularity Inc   0.92 $ 0.917  Millions$ 0.996  Millions
Timber Pharmaceuticals Inc   0.92 $ 0.727  Millions$ 0.793  Millions
Amphastar Pharmaceuticals Inc   0.91 $ 87.650  Millions$ 96.298  Millions
Corbus Pharmaceuticals Holdings Inc   0.91 $ 31.749  Millions$ 34.888  Millions

Date modified: 2026-09-08T15:09:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.